(Q46981597)

English

Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens

scientific article published on 8 March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16525415

Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens (English)

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16525415

nucleus accumbens

1 reference

based on heuristic

inferred from title

object named as

Isabelle Léna

3

0 references

author name string

Florence Razoux

1

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16525415

René Garcia

2

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16525415

language of work or name

0 references

publication date

8 March 2006

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16525415

Neuropsychopharmacology

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16525415

32

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16525415

3

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16525415

719-727

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16525415

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301057

0 references

Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Effects of the NMDA receptor antagonist ketamine on flavor memory: conditioned aversion, latent inhibition, and habituation of neophobia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Enhanced temporal resolution for the microdialysis monitoring of catecholamines and excitatory amino acids using capillary electrophoresis with laser-induced fluorescence detection. Analytical developments and in vitro validations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Dopaminergic modulation of prefrontal cortical input to nucleus accumbens neurons in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

The effect of NMDA antagonists in the radial arm maze task with an interposed delay.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Neurotransmitter interactions in schizophrenia--therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Converging Evidence of NMDA Receptor Hypofunction in the Pathophysiology of Schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Hippocampal morphometry in schizophrenia by high dimensional brain mapping.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Dopamine-dependent interactions between limbic and prefrontal cortical plasticity in the nucleus accumbens: disruption by cocaine sensitization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Gating of information flow within the limbic system and the pathophysiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Impaired recruitment of the hippocampus during conscious recollection in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Ketamine induces dopamine-dependent depression of evoked hippocampal activity in the nucleus accumbens in freely moving rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Phencyclidine disrupts acquisition and retention performance within a spatial continuous recognition memory task.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Ketamine and amphetamine both enhance synaptic transmission in the amygdala-nucleus accumbens pathway but with different time-courses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

The effects of a serotoninergic substrate of the nucleus accumbens on latent inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

From motivation to action: functional interface between the limbic system and the motor system.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Glutamate receptor dysfunction and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Prefrontal cortex activity in people with schizophrenia and control subjects. Evidence from positron emission tomography for remission of 'hypofrontality' with recovery from acute schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Latent inhibition disruption by MK-801 in a conditioned taste-aversion paradigm.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

The delayed effects of DTG and MK-801 on latent inhibition in a conditioned taste-aversion paradigm.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

On the significance of subterritories in the "accumbens" part of the rat ventral striatum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

21 January 2018

Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of hippocampal and amygdalar-evoked activity of nucleus accumbens neurons by dopamine: cellular mechanisms of input selection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

7 January 2021

based on heuristic

inferred from DOI database lookup

The pharmacology of latent inhibition as an animal model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of Glutamate Neurotransmission in the Prefrontal Cortex Sustains the Motoric and Dopaminergic Effects of Phencyclidine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

7 January 2021

based on heuristic

inferred from DOI database lookup

NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301057

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1301057

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16525415

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16525415

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46981597&oldid=2140732184"